Genetics and cardiomyopathy: Where are we now?

Article Type
Changed
Mon, 09/10/2018 - 11:14
Display Headline
Genetics and cardiomyopathy: Where are we now?
Article PDF
Author and Disclosure Information

Ross T. Murphy, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Randall C. Starling, MD, MPH
Head, Section of Heart Failure, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Address: Randall T. Starling, MD, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Starling has indicated that he has received grant or research support from the Novartis, Scios, Fujisawa, Acorn, and Guidant corporations, serves as a consultant for the Novartis and Acorn corporations, and is on the speakers’ bureaus of the Glaxo and Novartis corporations.
Issue
Cleveland Clinic Journal of Medicine - 72(6)
Publications
Topics
Page Number
465-466, 469-470, 472-473, 477-480, 482-483
Sections
Author and Disclosure Information

Ross T. Murphy, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Randall C. Starling, MD, MPH
Head, Section of Heart Failure, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Address: Randall T. Starling, MD, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Starling has indicated that he has received grant or research support from the Novartis, Scios, Fujisawa, Acorn, and Guidant corporations, serves as a consultant for the Novartis and Acorn corporations, and is on the speakers’ bureaus of the Glaxo and Novartis corporations.
Author and Disclosure Information

Ross T. Murphy, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Randall C. Starling, MD, MPH
Head, Section of Heart Failure, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Address: Randall T. Starling, MD, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Starling has indicated that he has received grant or research support from the Novartis, Scios, Fujisawa, Acorn, and Guidant corporations, serves as a consultant for the Novartis and Acorn corporations, and is on the speakers’ bureaus of the Glaxo and Novartis corporations.
Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 72(6)
Issue
Cleveland Clinic Journal of Medicine - 72(6)
Page Number
465-466, 469-470, 472-473, 477-480, 482-483
Page Number
465-466, 469-470, 472-473, 477-480, 482-483
Publications
Publications
Topics
Article Type
Display Headline
Genetics and cardiomyopathy: Where are we now?
Display Headline
Genetics and cardiomyopathy: Where are we now?
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media